Biologically targeted dual adaptive and innate nano-Immunotherapy for clear cell renal cell carcinoma treatment
This study demonstrates that MINPs are a versatile platform capable of facilitating immune cell engagement and the eradication of targeted ccRCC without causing systemic immune-related side effects.
Authors
- Kin Man Au (ORCID: https://orcid.org/0000-0001-9341-0479)
- Andrew Z. Wang (ORCID: https://orcid.org/0000-0002-9781-4494)
- Siqing Li (ORCID: https://orcid.org/0000-0001-8366-6032)
- Tian Zhang (ORCID: https://orcid.org/0000-0002-2652-0974)
Institutions
- Southwestern Medical Center (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Molecular Cancer
- Published
- 2025-06-18
- DOI
- https://doi.org/10.1186/s12943-025-02382-y
- Citations
- 1
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.67